• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Horm Metab Res . The transCampus Metabolic Training Programme Explores the Link of SARS-CoV-2 Virus to Metabolic Disease

tetano

Editor, Senior Moderator
Horm Metab Res


. 2021 Mar;53(3):204-206.
doi: 10.1055/a-1377-6583. Epub 2021 Mar 2.
The transCampus Metabolic Training Programme Explores the Link of SARS-CoV-2 Virus to Metabolic Disease


S R Bornstein[SUP] 1 2 3 4 [/SUP], K Guan[SUP] 5 [/SUP], C Brun?en[SUP] 6 [/SUP], G Mueller[SUP] 1 [/SUP], V Kamvissi-Lorenz[SUP] 2 [/SUP], R Lechler[SUP] 7 [/SUP], R Trembath[SUP] 8 [/SUP], M Mayr[SUP] 9 [/SUP], L Poston[SUP] 10 [/SUP], R Sancho[SUP] 1 11 [/SUP], IRTG Study Group:; S Ahmed[SUP] 12 [/SUP], E Alfar[SUP] 5 [/SUP], B Aljani[SUP] 12 [/SUP], T C Alves[SUP] 13 [/SUP], S Amiel[SUP] 14 [/SUP], C L Andoniadou[SUP] 1 15 [/SUP], M Bandral[SUP] 4 [/SUP], A Belavgeni[SUP] 1 [/SUP], I Berger[SUP] 1 [/SUP], A Birkenfeld[SUP] 1 2 16 [/SUP], E Bonifacio[SUP] 12 4 [/SUP], T Chavakis[SUP] 13 [/SUP], P Chawla[SUP] 4 [/SUP], P Choudhary[SUP] 2 [/SUP], A M Cujba[SUP] 1 [/SUP], L F Delgadillo Silva[SUP] 4 [/SUP], T Demcollari[SUP] 11 [/SUP], D M Drotar[SUP] 4 [/SUP], S Duin[SUP] 1 17 [/SUP], N N El-Agroudy[SUP] 1 [/SUP], A El-Armouche[SUP] 5 [/SUP], A Eugster[SUP] 12 [/SUP], M Gado[SUP] 1 [/SUP], A Gavalas[SUP] 4 [/SUP], M Gelinsky[SUP] 17 [/SUP], M Guirgus[SUP] 4 [/SUP], S Hansen[SUP] 5 [/SUP], E Hanton[SUP] 18 [/SUP], M Hasse[SUP] 5 [/SUP], H Henneicke[SUP] 1 [/SUP], C Heller[SUP] 1 [/SUP], H Hempel[SUP] 6 [/SUP], C Hogstrand[SUP] 19 [/SUP], D Hopkins[SUP] 20 [/SUP], L Jarc[SUP] 4 [/SUP], P M Jones[SUP] 14 [/SUP], M Kamel[SUP] 4 [/SUP], S K?mmerer[SUP] 5 [/SUP], A J F King[SUP] 14 [/SUP], A Kurzbach[SUP] 1 [/SUP], C Lambert[SUP] 11 [/SUP], Y Latunde-Dada[SUP] 7 [/SUP], I Lieberam[SUP] 11 [/SUP], J Liers[SUP] 21 [/SUP], J W Li[SUP] 12 [/SUP], A Linkermann[SUP] 1 [/SUP], S Locke[SUP] 1 [/SUP], B Ludwig[SUP] 1 3 4 12 [/SUP], T Manea[SUP] 11 [/SUP], F Maremonti[SUP] 1 [/SUP], Z Marinicova[SUP] 4 [/SUP], B M McGowan[SUP] 22 [/SUP], M Mickunas[SUP] 18 [/SUP], G Mingrone[SUP] 14 23 24 [/SUP], K Mohanraj[SUP] 13 [/SUP], H Morawietz[SUP] 6 [/SUP], N Ninov[SUP] 4 [/SUP], M Peakman[SUP] 18 [/SUP], S J Persaud[SUP] 14 [/SUP], J Pietzsch[SUP] 21 [/SUP], E Cachorro[SUP] 5 [/SUP], T J Pullen[SUP] 25 [/SUP], I Pyrina[SUP] 13 [/SUP], F Rubino[SUP] 14 [/SUP], A Santambrogio[SUP] 1 [/SUP], F Schepp[SUP] 1 [/SUP], P Schlinkert[SUP] 5 [/SUP], L D Scriba[SUP] 1 [/SUP], R Siow[SUP] 26 [/SUP], M Solimena[SUP] 4 27 [/SUP], F M Spagnoli[SUP] 11 [/SUP], S Speier[SUP] 4 [/SUP], A Stavridou[SUP] 12 [/SUP], C Steenblock[SUP] 1 [/SUP], A Strano[SUP] 5 [/SUP], P Taylor[SUP] 10 [/SUP], A Tiepner[SUP] 5 [/SUP], W Tonnus[SUP] 1 [/SUP], T Tree[SUP] 18 [/SUP], F Watt[SUP] 11 [/SUP], M Werdermann[SUP] 1 [/SUP], M Wilson[SUP] 25 [/SUP], N Yusuf[SUP] 18 [/SUP], C G Ziegler[SUP] 1 [/SUP]



Affiliations

Abstract

in English, German
Currently, we are experiencing a true pandemic of a communicable disease by the virus SARS-CoV-2 holding the whole world firmly in its grasp. Amazingly and unfortunately, this virus uses a metabolic and endocrine pathway via ACE2 to enter our cells causing damage and disease. Our international research training programme funded by the German Research Foundation has a clear mission to train the best students wherever they may come from to learn to tackle the enormous challenges of diabetes and its complications for our society. A modern training programme in diabetes and metabolism does not only involve a thorough understanding of classical physiology, biology and clinical diabetology but has to bring together an interdisciplinary team. With the arrival of the coronavirus pandemic, this prestigious and unique metabolic training programme is facing new challenges but also new opportunities. The consortium of the training programme has recognized early on the need for a guidance and for practical recommendations to cope with the COVID-19 pandemic for the community of patients with metabolic disease, obesity and diabetes. This involves the optimal management from surgical obesity programmes to medications and insulin replacement. We also established a global registry analyzing the dimension and role of metabolic disease including new onset diabetes potentially triggered by the virus. We have involved experts of infectious disease and virology to our faculty with this metabolic training programme to offer the full breadth and scope of expertise needed to meet these scientific challenges. We have all learned that this pandemic does not respect or heed any national borders and that we have to work together as a global community. We believe that this transCampus metabolic training programme provides a prime example how an international team of established experts in the field of metabolism can work together with students from all over the world to address a new pandemic.
 
Back
Top Bottom